Alveus-Therapeutics-Announces-Second-and-Final-Closing-of-Oversubscribed-Series-A-Bringing-Total-Financing-to-197-Million-to-Advance-Next-Generation-Therapies-for-Obesity-and-Metab.html

Alveus Therapeutics Announces Second and Final Closing of Oversubscribed Series A, Bringing Total Financing to $197 Million to Advance Next‑Generation Therapies for Obesity and Metabolic Diseases

Feb 24, 2026